Ockelbo-Lundgren
Tracked across 3 events · 24 articles · First seen Jun 10, 2026 · Last active Aug 10, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Ockelbo-Lundgren, CEO of Immunic, will participate in a fireside chat and one-on-one investor meetings at the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit, representing Immunic.
Jun 10, 2026 · 10 articles
Business
Impact: CEO Ockelbo-Lundgren will attend the conferences and participate in meetings and a fireside chat, representing Immunic.
Jul 09, 2026 · 8 articles
Business
Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company developing oral therapies for neurologic diseases, announced the appointment of Elena Ridloff, CFA, to its Board of Directors, effective August 6, 2026. Ridloff brings over two decades…
Impact: As CEO of Immunic, Ockelbo-Lundgren commented on the appointment and the company's upcoming clinical milestones.
Aug 10, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Ockelbo-Lundgren live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard